Challenges in assessing the immunization status of adults in Germany-lessons from a population-based VACCELERATE survey on polio vaccination.
Infection control
Pandemic preparedness
Public health
Surveillance
Vaccination coverage
Vaccine preventable
Journal
Infection
ISSN: 1439-0973
Titre abrégé: Infection
Pays: Germany
ID NLM: 0365307
Informations de publication
Date de publication:
28 May 2024
28 May 2024
Historique:
received:
14
02
2024
accepted:
13
05
2024
medline:
29
5
2024
pubmed:
29
5
2024
entrez:
28
5
2024
Statut:
aheadofprint
Résumé
Considering the re-emergence of poliomyelitis (PM) in non-endemic regions, it becomes apparent that vaccine preventable diseases can rapidly develop epi- or even pandemic potential. Evaluation of the current vaccination status is required to inform patients, health care providers and policy makers about vaccination gaps. Between October 28 2022 and November 23 2022, 5,989 adults from the VACCELEREATE Volunteer Registry completed an electronic case report form on their previous PM vaccine doses including number, types/-valencies and the time of administration based on their vaccination records. A uni-/multivariable regression analysis was performed to assess associations in participant characteristics and immunization status. Among German volunteers (n = 5,449), complete PM immunization schedule was found in 1,981 (36%) participants. Uncertain immunization, due to unknown previous PM vaccination (n = 313, 6%), number of doses (n = 497, 9%), types/-valencies (n = 1,233, 23%) or incoherent immunization schedule (n = 149, 3%) was found in 40% (n = 2,192). Out of 1,276 (23%) participants who reported an incomplete immunization schedule, 62 (1%) never received any PM vaccine. A total of 5,074 (93%) volunteers reported having been vaccinated at least once and 2,087 (38%) indicated that they received vaccination within the last ten years. Female sex, younger age, as well as availability of first vaccination record were characteristics significantly associated with complete immunization (p < 0.001). Full PM immunization schedule was low and status frequently classified as uncertain due to lack of details on administered doses. There is an obviousneed for improved recording to enable long-term access to detailed vaccination history in the absence of a centralized immunization register.
Identifiants
pubmed: 38806974
doi: 10.1007/s15010-024-02296-9
pii: 10.1007/s15010-024-02296-9
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s).
Références
Bayham J, Fenichel EP. Impact of school closures for COVID-19 on the US health-care workforce and net mortality: a modelling study. Lancet Public Health. 2020;5:e271–8. https://doi.org/10.1016/S2468-2667(20)30082-7 .
doi: 10.1016/S2468-2667(20)30082-7
pubmed: 32251626
pmcid: 7270508
Bourrier MS, Deml MJ. The legacy of the pandemic preparedness regime: an integrative review. Int J Public Health. 2022;67:1604961. https://doi.org/10.3389/ijph.2022.1604961 .
doi: 10.3389/ijph.2022.1604961
pubmed: 36545404
pmcid: 9760677
Chen YT. Effect of vaccination patterns and vaccination rates on the spread and mortality of the COVID-19 pandemic. Health Policy Technol. 2023;12:100699. https://doi.org/10.1016/j.hlpt.2022.100699 .
doi: 10.1016/j.hlpt.2022.100699
pubmed: 36415885
Mbunge E, Dzinamarira T, Fashoto SG, Batani J. Emerging technologies and COVID-19 digital vaccination certificates and passports. Public Health Pract (Oxf). 2021;2:100136. https://doi.org/10.1016/j.puhip.2021.100136 .
doi: 10.1016/j.puhip.2021.100136
pubmed: 33977281
Wiot F, Shirley J, Prugnola A, Di Pasquale A, Philip R. Challenges facing vaccinators in the 21(st) century: results from a focus group qualitative study. Hum Vaccin Immunother. 2019;15:2806–15. https://doi.org/10.1080/21645515.2019.1621147 .
doi: 10.1080/21645515.2019.1621147
pubmed: 31116642
pmcid: 6930098
Rieck T, Feig M, Siedler A. Impfquoten von Kinderschutzimpfungen in Deutschland –aktuelle Ergebnisse aus der RKI-Impfsurveillance. Epidemiologisches Bulletin. 2022;48:3–25. https://doi.org/10.25646/10838 .
doi: 10.25646/10838
Viktorova EG, Khattar S, Samal S, Belov GA. Poliovirus Replicon RNA generation, transfection, packaging, and quantitation of replication. Curr Protoc Microbiol. 2018. https://doi.org/10.1002/cpmc.47 .
doi: 10.1002/cpmc.47
pubmed: 29512114
pmcid: 5844361
Pait CF. Virology of poliomyelitis. Calif Med. 1950;73:391–3.
pubmed: 14778005
pmcid: 1520596
Bigouette JP, Wilkinson AL, Tallis G, Burns CC, Wassilak SGF, Vertefeuille JF. Progress toward polio eradication - worldwide, January 2019-June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1129–35. https://doi.org/10.15585/mmwr.mm7034a1 .
doi: 10.15585/mmwr.mm7034a1
pubmed: 34437527
pmcid: 8389387
World Health A. Global eradication of poliomyelitis by the year 2000. Geneva: World Health Organization; 1988.
Kew OM, Cochi SL, Jafari HS, Wassilak SG, Mast EE, Diop OM, et al. Possible eradication of wild poliovirus type 3–worldwide, 2012. MMWR Morb Mortal Wkly Rep. 2014;63:1031–3.
pubmed: 25393222
pmcid: 5779498
Alleman MM, Jorba J, Henderson E, Diop OM, Shaukat S, Traoré MA, et al. Update on vaccine-derived poliovirus outbreaks - worldwide, January 2020-June 2021. MMWR Morb Mortal Wkly Rep. 2021;70:1691–9. https://doi.org/10.15585/mmwr.mm7049a1 .
doi: 10.15585/mmwr.mm7049a1
pubmed: 34882653
pmcid: 8659190
Khetsuriani N, Perehinets I, Nitzan D, Popovic D, Moran T, Allahverdiyeva V, et al. Responding to a cVDPV1 outbreak in Ukraine: Implications, challenges and opportunities. Vaccine. 2017;35:4769–76. https://doi.org/10.1016/j.vaccine.2017.04.036 .
doi: 10.1016/j.vaccine.2017.04.036
pubmed: 28528761
pmcid: 10465089
Leggiadro RJ. Public health response to a case of paralytic poliomyelitis in an unvaccinated person and detection of poliovirus in wastewater—New York, June-August 2022. Pediatr Infect Dis J. 2022;41:898. https://doi.org/10.1097/inf.0000000000003696 .
doi: 10.1097/inf.0000000000003696
pubmed: 36102713
Klapsa D, Wilton T, Zealand A, Bujaki E, Saxentoff E, Troman C, et al. Sustained detection of type 2 poliovirus in London sewage between February and July, 2022, by enhanced environmental surveillance. Lancet. 2022. https://doi.org/10.1016/s0140-6736(22)01804-9 .
doi: 10.1016/s0140-6736(22)01804-9
pubmed: 36243024
pmcid: 9627700
Poethko-Müller C, Schmitz R. Vaccination coverage in German adults: results of the German health interview and examination survey for adults (DEGS1). Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013;56:845–57. https://doi.org/10.1007/s00103-013-1693-6 .
doi: 10.1007/s00103-013-1693-6
pubmed: 23703506
Robert-Koch-Institut. 2022 Impfquoten von Kinderschutzimpfungen in Deutschland. Epidemiologisches Bulletin 48/2022.
Feinstein S, Poleacovschi C, Drake R, Winters LA. States and refugee integration: a comparative analysis of France, Germany, and Switzerland. J Int Migr Integr. 2022;23:2167–94. https://doi.org/10.1007/s12134-021-00929-8 .
doi: 10.1007/s12134-021-00929-8
Cojocaru E, Cojocaru C, Cojocaru E, Oancea CI. Health risks during ukrainian humanitarian crisis. Risk Manag Healthc Policy. 2022;15:1775–81. https://doi.org/10.2147/rmhp.S375021 .
doi: 10.2147/rmhp.S375021
pubmed: 36171868
pmcid: 9512537
Stoeckel F, Carter C, Lyons BA, Reifler J. The politics of vaccine hesitancy in Europe. Eur J Public Health. 2022;32:636–42. https://doi.org/10.1093/eurpub/ckac041 .
doi: 10.1093/eurpub/ckac041
pubmed: 35522721
pmcid: 9341843
Salmanton-García J, Stewart FA, Heringer S, Koniordou M, Álvarez-Barco E, Argyropoulos CD, et al. VACCELERATE volunteer registry: a European study participant database to facilitate clinical trial enrolment. Vaccine. 2022;40:4090–7. https://doi.org/10.1016/j.vaccine.2022.05.022 . Accessed 5 May 2023
doi: 10.1016/j.vaccine.2022.05.022
pubmed: 35659449
pmcid: 9159788
Robert-Koch-Institut. Tasks and Aims. https://www.rki.de/EN/Content/Institute/institute_node.html .
Robert-Koch-Institut. KV-Impfsurveillance: Auswertung von Abrechnungsdaten der Kassenärztlichen Vereinigungen. (2023). https://www.rki.de/DE/Content/Infekt/Impfen/Impfstatus/kv-impfsurveillance/kvis_node.html#doc2391060bodyText2 . Accessed 05 May 2023.
Robert-Koch-Institut. Schutzimpfung gegen Poliomyelitis: Häufig gestellte Fragen und Antworten. (2022). https://www.rki.de/SharedDocs/FAQ/Impfen/Poliomyelitis/FAQ-Liste_Poliomyelitis_Impfen.html . Accessed 02 May 2023.
Reiter S. Ausgewählte Daten zum Impf- und Immunstatus in Deutschland. Bundesgesundheitsblatt - Gesundheitsforschung -Gesundheitsschutz. 2004;47:1144–50. https://doi.org/10.1007/s00103-004-0952-y .
doi: 10.1007/s00103-004-0952-y
pubmed: 15583885
Robert-Koch-Institut. Archiv der STIKO-Empfehlungen. (2023). https://www.rki.de/DE/Content/Kommissionen/STIKO/Empfehlungen/Archiv/seit_1972/archiv_tab.html . Accessed 05 May 2023.
Bundesamt S. Bevölkerung - Anzahl der Einwohner in den Bundesländern in Deutschland am 31. Dezember 2021. (2022). https://de.statista.com/statistik/daten/studie/71085/umfrage/verteilung-der-einwohnerzahl-nach-bundeslaendern/ . Accessed 05 May 2023.
Plans-Rubió P. Evaluation of the establishment of herd immunity in the population by means of serological surveys and vaccination coverage. Hum Vaccin Immunother. 2012;8:184–8. https://doi.org/10.4161/hv.18444 .
doi: 10.4161/hv.18444
pubmed: 22426372
European Centre for Disease Prevention and Control. Wild-type poliovirus 1 transmission in Israel – what is the risk to the EU/EEA? Stockholm: ECDC. 2013. polio-risk-assessment-transmission-in-Israel.pdf (europa.eu). Accessed 05 May 2024.
Mercader-Barceló J, Otu A, Townley TA, Adepoju P, Walley J, Okoibhole LO, et al. Rare recurrences of poliomyelitis in non-endemic countries after eradication: a call for global action. Lancet Microbe. 2022. https://doi.org/10.1016/S2666-5247(22)00253-1 .
doi: 10.1016/S2666-5247(22)00253-1
pubmed: 36084661
Diedrich S, Claus H, Schreier E. Immunity status against poliomyelitis in Germany: determination of cut-off values in International Units. BMC Infect Dis. 2002;2:2. https://doi.org/10.1186/1471-2334-2-2 .
doi: 10.1186/1471-2334-2-2
pubmed: 11943068
pmcid: 101379
Applewhite A, Stancampiano FF, Harris DM, Manaois A, Dimuna J, Glenn J, et al. A retrospective analysis of gender-based difference in adherence to influenza vaccination during the 2018–2019 season. J Prim Care Community Health. 2020;11:2150132720958532. https://doi.org/10.1177/2150132720958532 .
doi: 10.1177/2150132720958532
pubmed: 32930035
pmcid: 7495515
Ray JG, Park AL. SARS-CoV-2 vaccination, ABO blood group and risk of COVID-19: population-based cohort study. BMJ Open. 2022;12:e059944. https://doi.org/10.1136/bmjopen-2021-059944 .
doi: 10.1136/bmjopen-2021-059944
pubmed: 35851010
Matoff-Stepp S, Applebaum B, Pooler J, Kavanagh E. Women as health care decision-makers: implications for health care coverage in the United States. J Health Care Poor Underserved. 2014;25:1507–13. https://doi.org/10.1353/hpu.2014.0154 .
doi: 10.1353/hpu.2014.0154
pubmed: 25418222
Benedikt M, Tobias H. vacuna. (2019–2023). https://vacuna.io/ . Accessed 04 May 2023.